Certara: Why It’s A Hold For Now (NASDAQ:CERT)


Two doctors in hospital hallway discussing electronic patient record


Investment Thesis

Certara Inc. (NASDAQ:CERT) is a leading provider of model-informed drug development and regulatory science solutions to biopharmaceutical and medical device companies. The company operates in a growing market, driven primarily by tailwinds such as patients having a

The market outlook for pharmaceutical industry

Market Outlook (GrandViewResearch)

The assets that the company currently has

Assets (Balance Sheet)

The liabilites that the company has

Liabilities (Balance Sheet)

The last 12 months stock price

Stock Price (Seeking Alpha)